State Street Global Advisors Announces Impact of Receiving Payment

State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today announced that the SPDR Exchange Traded Fund (ETF) listed in the table below received a payment as an authorized claimant from a class action settlement related to Juno Therapeutics, Inc.* securities litigation.

The total payment to be received by the Fund is listed below. When the Fund calculates its net asset value (“NAV”) per share on Thursday, October 10, 2019, it is estimated that the Fund’s NAV will be impacted by the amount stated below based on shares outstanding as of October 8, 2019.

Fund		Payment Amount		Shares Outstanding as of October 8, 2019		Per Share Impact
SPDR S&P Biotech ETF (XBI)		$2,451,558		46,250,000		$0.0530

* On January 22, 2018, Juno Therapeutics, Inc. (NASDAQ:JUNO) was acquired by Celgene Corporation (NASDAQ:CELG)

About SPDR Exchange Traded Funds

SPDR ETFs are a comprehensive family spanning an array of international and domestic asset classes. SPDR ETFs are managed by SSGA Funds Management, Inc., a registered investment adviser and wholly owned subsidiary of State Street Corporation. The funds provide investors with the flexibility to select investments that are precisely aligned to their investment strategy. Recognized as an industry pioneer, State Street created the first US listed ETF in 1993 (SPDR S&P 500 – Ticker SPY) and has remained on the forefront of responsible innovation, as evidenced by the introduction of many ground-breaking products, including first-to-market launches with gold, international real estate, international fixed income, and sector ETFs. For more information, visit www.spdrs.com.